ADIPOQ and obesity due to melanocortin 4 receptor deficiency: Moreover, troxerutin ameliorated obesity and decline of circulating adiponectin in HFD-treated mouse, indicating these improvements of hepatic glucose disorders might be mediated by its anti-obesity effect.